-
Je něco špatně v tomto záznamu ?
Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene
C. Barba, I. Blumcke, MR. Winawer, T. Hartlieb, HC. Kang, L. Grisotto, M. Chipaux, CG. Bien, B. Heřmanovská, BE. Porter, HGW. Lidov, V. Cetica, FG. Woermann, JA. Lopez-Rivera, PD. Canoll, I. Mader, L. D'Incerti, S. Baldassari, E. Yang, A....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu multicentrická studie, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
R01 NS114122
NINDS NIH HHS - United States
R01 NS115017
NINDS NIH HHS - United States
P50 HD105351
NICHD NIH HHS - United States
R01 NS089552
NINDS NIH HHS - United States
R21 NS101303
NINDS NIH HHS - United States
R01 NS094596
NINDS NIH HHS - United States
R01 NS117544
NINDS NIH HHS - United States
- MeSH
- elektroencefalografie MeSH
- epilepsie * genetika chirurgie diagnóza MeSH
- lidé MeSH
- mozek diagnostické zobrazování chirurgie patologie MeSH
- refrakterní epilepsie * genetika chirurgie patologie MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- záchvaty patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND AND OBJECTIVES: The SLC35A2 gene, located at chromosome Xp11.23, encodes for a uridine diphosphate-galactose transporter. We describe clinical, genetic, neuroimaging, EEG, and histopathologic findings and assess possible predictors of postoperative seizure and cognitive outcome in 47 patients with refractory epilepsy and brain somatic SLC35A2 gene variants. METHODS: This is a retrospective multicenter study where we performed a descriptive analysis and classical hypothesis testing. We included the variables of interest significantly associated with the outcomes in the generalized linear models. RESULTS: Two main phenotypes were associated with brain somatic SLC35A2 variants: (1) early epileptic encephalopathy (EE, 39 patients) with epileptic spasms as the predominant seizure type and moderate to severe intellectual disability and (2) drug-resistant focal epilepsy (DR-FE, 8 patients) associated with normal/borderline cognitive function and specific neuropsychological deficits. Brain MRI was abnormal in all patients with EE and in 50% of those with DR-FE. Histopathology review identified mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy in 44/47 patients and was inconclusive in 3. The 47 patients harbored 42 distinct mosaic SLC35A2 variants, including 14 (33.3%) missense, 13 (30.9%) frameshift, 10 (23.8%) nonsense, 4 (9.5%) in-frame deletions/duplications, and 1 (2.4%) splicing variant. Variant allele frequencies (VAFs) ranged from 1.4% to 52.6% (mean VAF: 17.3 ± 13.5). At last follow-up (35.5 ± 21.5 months), 30 patients (63.8%) were in Engel Class I, of which 26 (55.3%) were in Class IA. Cognitive performances remained unchanged in most patients after surgery. Regression analyses showed that the probability of achieving both Engel Class IA and Class I outcomes, adjusted by age at seizure onset, was lower when the duration of epilepsy increased and higher when postoperative EEG was normal or improved. Lower brain VAF was associated with improved postoperative cognitive outcome in the analysis of associations, but this finding was not confirmed in regression analyses. DISCUSSION: Brain somatic SLC35A2 gene variants are associated with 2 main clinical phenotypes, EE and DR-FE, and a histopathologic diagnosis of MOGHE. Additional studies will be needed to delineate any possible correlation between specific genetic variants, mutational load in the epileptogenic tissue, and surgical outcomes.
Boston Children's Hospital and Harvard Medical School MA
Broad Institute of Harvard and M 1 T Cambridge MA
Charles University 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic
Columbia University New York NY
From the IRCCS Meyer Children's Hospital Florence Italy
IRCCS Meyer Children's Hospital Florence Italy
Korea Advanced Institute of Science and Technology Daejeon South Korea
Krankenhaus Mara Bielefeld University Medical School Germany
Lucile Packard Children's Hospital at Stanford University School of Medicine Stanford CA
Neurorehabilitation and Epileptology Vogtareuth Germany
Rothschild Foundation Hospital Paris France
Sorbonne University Paris Brain Institute INSERM CNRS AP HP Pitié Salpêtrière Hospital France
Stanford University School of Medicine Stanford CA
University Hospital Erlangen Germany
University of Florence Florence Italy
University of Maryland School of Medicine Baltimore MD
Yonsei University College of Medicine Seoul Republic of Korea
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004486
- 003
- CZ-PrNML
- 005
- 20240716080115.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1212/WNL.0000000000201471 $2 doi
- 035 __
- $a (PubMed)36307217
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Barba, Carmen $u IRCCS Meyer Children's Hospital, Florence, Italy $1 https://orcid.org/0000000154455842
- 245 10
- $a Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene / $c C. Barba, I. Blumcke, MR. Winawer, T. Hartlieb, HC. Kang, L. Grisotto, M. Chipaux, CG. Bien, B. Heřmanovská, BE. Porter, HGW. Lidov, V. Cetica, FG. Woermann, JA. Lopez-Rivera, PD. Canoll, I. Mader, L. D'Incerti, S. Baldassari, E. Yang, A. Gaballa, H. Vogel, B. Straka, L. Macconi, T. Polster, GA. Grant, L. Krsková, HJ. Shin, A. Ko, PB. Crino, P. Krsek, JH. Lee, D. Lal, S. Baulac, A. Poduri, R. Guerrini, SLC35A2 Study Group
- 520 9_
- $a BACKGROUND AND OBJECTIVES: The SLC35A2 gene, located at chromosome Xp11.23, encodes for a uridine diphosphate-galactose transporter. We describe clinical, genetic, neuroimaging, EEG, and histopathologic findings and assess possible predictors of postoperative seizure and cognitive outcome in 47 patients with refractory epilepsy and brain somatic SLC35A2 gene variants. METHODS: This is a retrospective multicenter study where we performed a descriptive analysis and classical hypothesis testing. We included the variables of interest significantly associated with the outcomes in the generalized linear models. RESULTS: Two main phenotypes were associated with brain somatic SLC35A2 variants: (1) early epileptic encephalopathy (EE, 39 patients) with epileptic spasms as the predominant seizure type and moderate to severe intellectual disability and (2) drug-resistant focal epilepsy (DR-FE, 8 patients) associated with normal/borderline cognitive function and specific neuropsychological deficits. Brain MRI was abnormal in all patients with EE and in 50% of those with DR-FE. Histopathology review identified mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy in 44/47 patients and was inconclusive in 3. The 47 patients harbored 42 distinct mosaic SLC35A2 variants, including 14 (33.3%) missense, 13 (30.9%) frameshift, 10 (23.8%) nonsense, 4 (9.5%) in-frame deletions/duplications, and 1 (2.4%) splicing variant. Variant allele frequencies (VAFs) ranged from 1.4% to 52.6% (mean VAF: 17.3 ± 13.5). At last follow-up (35.5 ± 21.5 months), 30 patients (63.8%) were in Engel Class I, of which 26 (55.3%) were in Class IA. Cognitive performances remained unchanged in most patients after surgery. Regression analyses showed that the probability of achieving both Engel Class IA and Class I outcomes, adjusted by age at seizure onset, was lower when the duration of epilepsy increased and higher when postoperative EEG was normal or improved. Lower brain VAF was associated with improved postoperative cognitive outcome in the analysis of associations, but this finding was not confirmed in regression analyses. DISCUSSION: Brain somatic SLC35A2 gene variants are associated with 2 main clinical phenotypes, EE and DR-FE, and a histopathologic diagnosis of MOGHE. Additional studies will be needed to delineate any possible correlation between specific genetic variants, mutational load in the epileptogenic tissue, and surgical outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a refrakterní epilepsie $x genetika $x chirurgie $x patologie $7 D000069279
- 650 _2
- $a mozek $x diagnostické zobrazování $x chirurgie $x patologie $7 D001921
- 650 12
- $a epilepsie $x genetika $x chirurgie $x diagnóza $7 D004827
- 650 _2
- $a záchvaty $x patologie $7 D012640
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a elektroencefalografie $7 D004569
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Blumcke, Ingmar $u University Hospital Erlangen, Germany
- 700 1_
- $a Winawer, Melodie R $u Columbia University, New York, NY
- 700 1_
- $a Hartlieb, Till $u Neurorehabilitation and Epileptology, Vogtareuth, Germany $1 https://orcid.org/0000000208545537
- 700 1_
- $a Kang, Hoon-Chul $u Yonsei University College of Medicine, Seoul, Republic of Korea
- 700 1_
- $a Grisotto, Laura $u University of Florence, Florence, Italy
- 700 1_
- $a Chipaux, Mathilde $u Rothschild Foundation Hospital, Paris, France
- 700 1_
- $a Bien, Christian G $u Krankenhaus Mara, Bielefeld University, Medical School, Germany $1 https://orcid.org/0000000322258654
- 700 1_
- $a Heřmanovská, Barbora $u Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Porter, Brenda E $u Stanford University, School of Medicine Stanford, CA $1 https://orcid.org/0000000163467327
- 700 1_
- $a Lidov, Hart G W $u Boston Children's Hospital and Harvard Medical School, MA
- 700 1_
- $a Cetica, Valentina $u From the IRCCS Meyer Children's Hospital, Florence, Italy
- 700 1_
- $a Woermann, Friedrich G $u Krankenhaus Mara, Bielefeld University, Medical School, Germany
- 700 1_
- $a Lopez-Rivera, Javier A $u Cleveland Clinic, Cleveland, OH
- 700 1_
- $a Canoll, Peter D $u Columbia University, New York, NY
- 700 1_
- $a Mader, Irina $u Neurorehabilitation and Epileptology, Vogtareuth, Germany $1 https://orcid.org/0000000252614624
- 700 1_
- $a D'Incerti, Ludovico $u From the IRCCS Meyer Children's Hospital, Florence, Italy
- 700 1_
- $a Baldassari, Sara $u Sorbonne University, Paris Brain Institute (ICM), INSERM, CNRS, AP-HP, Pitié-Salpêtrière Hospital, France $1 https://orcid.org/0000000348512796
- 700 1_
- $a Yang, Edward $u Boston Children's Hospital and Harvard Medical School, MA
- 700 1_
- $a Gaballa, Ahmed $u Krankenhaus Mara, Bielefeld University, Medical School, Germany
- 700 1_
- $a Vogel, Hannes $u Stanford University, School of Medicine Stanford, CA
- 700 1_
- $a Straka, Barbora $u Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000184482833 $7 xx0319616
- 700 1_
- $a Macconi, Letizia $u From the IRCCS Meyer Children's Hospital, Florence, Italy
- 700 1_
- $a Polster, Tilman $u Krankenhaus Mara, Bielefeld University, Medical School, Germany
- 700 1_
- $a Grant, Gerald A $u Lucile Packard Children's Hospital at Stanford University, School of Medicine Stanford, CA
- 700 1_
- $a Krsková, Lenka $u Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Shin, Hui Jin $u Yonsei University College of Medicine, Seoul, Republic of Korea
- 700 1_
- $a Ko, Ara $u Korea Advanced Institute of Science and Technology, Daejeon, South Korea
- 700 1_
- $a Crino, Peter B $u University of Maryland School of Medicine, Baltimore, MD
- 700 1_
- $a Krsek, Pavel $u Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000230711589 $7 ntka173081
- 700 1_
- $a Lee, Jeong Ho $u Korea Advanced Institute of Science and Technology, Daejeon, South Korea
- 700 1_
- $a Lal, Dennis $u Broad Institute of Harvard and M.I.T, Cambridge, MA
- 700 1_
- $a Baulac, Stéphanie $u Sorbonne University, Paris Brain Institute (ICM), INSERM, CNRS, AP-HP, Pitié-Salpêtrière Hospital, France $1 https://orcid.org/0000000164304693
- 700 1_
- $a Poduri, Annapurna $u Boston Children's Hospital and Harvard Medical School, MA
- 700 1_
- $a Guerrini, Renzo $u From the IRCCS Meyer Children's Hospital, Florence, Italy $1 https://orcid.org/0000000272727079
- 710 2_
- $a SLC35A2 Study Group
- 773 0_
- $w MED00003491 $t Neurology $x 1526-632X $g Roč. 100, č. 5 (2023), s. e528-e542
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36307217 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20240716080112 $b ABA008
- 999 __
- $a ok $b bmc $g 1924907 $s 1190695
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 100 $c 5 $d e528-e542 $e 20221028 $i 1526-632X $m Neurology $n Neurology $x MED00003491
- GRA __
- $a R01 NS114122 $p NINDS NIH HHS $2 United States
- GRA __
- $a R01 NS115017 $p NINDS NIH HHS $2 United States
- GRA __
- $a P50 HD105351 $p NICHD NIH HHS $2 United States
- GRA __
- $a R01 NS089552 $p NINDS NIH HHS $2 United States
- GRA __
- $a R21 NS101303 $p NINDS NIH HHS $2 United States
- GRA __
- $a R01 NS094596 $p NINDS NIH HHS $2 United States
- GRA __
- $a R01 NS117544 $p NINDS NIH HHS $2 United States
- LZP __
- $a Pubmed-20230418